Skip to main content

Table 2 Univariate and multivariate cox regression analysis of factors associated with OS and DFS

From: Expression and prognostic value of APOBEC2 in gastric adenocarcinoma and its association with tumor-infiltrating immune cells

 

Overall survival (OS)

Disease-free survival (DFS)

 

Univariate analysis of OS Multivariate analysis of OS

Univariate analysis of DFS Multivariate analysis of DFS

Variables

HR (95% CI)

P value

HR (95% CI)

P value

HR (95% CI)

P value

HR (95% CI)

P value

APOBEC2

        

Positive

0.656 (0.486,0.884)

0.006

0.816 (0.574,1.161)

0.259

0.653 (0.485,0.881)

0.005

0.821 (0.578,1.166)

0.270

Negative

        

Age (median,58 years)

        

> 58

1.277 (0.952,1.715)

0.103

  

1.278 (0.952,1.715)

0.103

  

≤ 58

        

Gender

        

Female

1.233 (0.899,1.692)

0.194

  

1.221 (0.890,1.676)

0.215

  

Male

        

Size(median,4.0 cm)

        

> 4.0

3.217 (2.386,4.335)

< 0.001

1.878 (1.361,2.593)

< 0.001

3.232 (2.398,4.357)

< 0.001

1.896 (1.375,2.615)

< 0.001

≤ 4.0

        

Differentiation grade

        

Poor

1.754 (1.294,2.377)

< 0.001

1.397 (0.948,2.059)

0.091

1.747 (1.290,2.368)

< 0.001

1.411 (0.958,2.080)

0.082

Well + moderate

        

Lauren’s histologic type

        

Diffuse

1.327 (0.983,1.792)

0.065

0.936 (0.615,1.426)

0.758

1.316 (0.975,1.777)

0.073

0.915 (0.602,1.389)

0.677

Intestinal

        

TNM stage

        

III + VI

4.867 (3.537,6.699)

< 0.001

3.215 (2.253,4.589)

< 0.001

4.870 (3.539,6.702)

< 0.001

3.205 (2.248,4.570)

< 0.001

I + II

        

Chemotherapy

        

No

0.336 (0.225,0.503)

< 0.001

0.648 (0.422,0.997)

0.049

0.335 (0.224,0.502)

< 0.001

0.643 (0.418,0.987)

0.044

Yes

        
  1. HR hazard ratio, CI confidence interval, APOBEC2 apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 2, TNM tumor node metastasis